Medicenna Therapeutics Corp (MDNA) - Total Liabilities

Latest as of December 2025: CA$6.85 Million CAD ≈ $4.96 Million USD

Based on the latest financial reports, Medicenna Therapeutics Corp (MDNA) has total liabilities worth CA$6.85 Million CAD (≈ $4.96 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Medicenna Therapeutics Corp to track the company's year-over-year net asset growth rate.

Medicenna Therapeutics Corp - Total Liabilities Trend (2014–2025)

This chart illustrates how Medicenna Therapeutics Corp's total liabilities have evolved over time, based on quarterly financial data.

Medicenna Therapeutics Corp Competitors by Total Liabilities

The table below lists competitors of Medicenna Therapeutics Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Lodzia TA:LODZ	Israel	ILA234.01 Million
Scope Industries Bhd KLSE:0028	Malaysia	RM13.57 Million
SCI Electric Public Company Limited BK:SCI	Thailand	฿911.77 Million
SeaTwirl AB ST:STW	Sweden	Skr76.20 Million
QMINES LTD F:81V	Germany	€3.41 Million
DAP Corporation KQ:066900	Korea	₩132.57 Billion
Brill Shoe Industries Ltd TA:BRIL	Israel	ILA452.94 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Medicenna Therapeutics Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MDNA market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.68	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	2.20	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.52	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medicenna Therapeutics Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medicenna Therapeutics Corp (2014–2025)

The table below shows the annual total liabilities of Medicenna Therapeutics Corp from 2014 to 2025.

Year	Total Liabilities	Change
2025-03-31	CA$9.29 Million ≈ $6.72 Million	-33.39%
2024-03-31	CA$13.94 Million ≈ $10.09 Million	+100.33%
2023-03-31	CA$6.96 Million ≈ $5.03 Million	+165.55%
2022-03-31	CA$2.62 Million ≈ $1.90 Million	-36.18%
2021-03-31	CA$4.11 Million ≈ $2.97 Million	+122.34%
2020-03-31	CA$1.85 Million ≈ $1.34 Million	-28.15%
2019-03-31	CA$2.57 Million ≈ $1.86 Million	+16.18%
2018-03-31	CA$2.21 Million ≈ $1.60 Million	-71.73%
2017-03-31	CA$7.83 Million ≈ $5.66 Million	+122.97%
2016-03-31	CA$3.51 Million ≈ $2.54 Million	+1102.65%
2015-03-31	CA$291.87K ≈ $211.13K	-64.83%
2014-03-31	CA$829.89K ≈ $600.33K	--

About Medicenna Therapeutics Corp

TO:MDNA Canada Biotechnology

Market Cap

$21.72 Million

CA$30.03 Million CAD

Market Cap Rank

#24791 Global

#954 in Canada

Share Price

CA$0.36

Change (1 day)

+2.86%

52-Week Range

CA$0.35 - CA$1.64

All Time High

CA$7.00